Use access key #2 to skip to page content.
$3.46 -0.19 (-5.21%)
5/16/2008 3:41 PM

XTENT, Inc. (XTNT)

CAPS Rating:
*

A development stage medical device company, which focused on developing and commercializing its customizable drug eluting stent systems for the treatment of coronary artery disease or CAD.

View All Commentary (XTNT)

Recs

1

Avatar 80brown (99.01) Submitted: 6/01/07 3:44 PM : Underperform Start Price: $9.60 XTNT Score: 56.72

Trading at 324% intrinsic value.

Report this Post Replies: 0 | Reply

Featured Broker Partners